Through NRF2-driven GSH synthesis, tumor cells are protected from oxidative stress, which contributes to chemotherapy resistance by reducing the cytotoxic effects of ROS generated during treatment
4 minute read Summary Semaglutide , the active ingredient in Wegovy, is a GLP-1 receptor agonist used for weight loss by mimicking a natural hormone that regulates appetite, digestion, and blood sugar
In addition, trials on human and mice showed GLP-1 receptor agonists benefits in heart failure, endothelial lining and,myocardial ischemia.First, heart failure clinical trials on human showed at New York Heart Association involved diabetic patients with stage 3-4 heart failure better response with Glp-1 continuous infusion over 12 weeks duration in the form of better left ventricular ejection fraction and 6 minute walk over 48 hours trial of GLP-1 infusion in nondiabetic patients with stage 2-3 heart failure
Commercial products marketed as GLP-1 patches do not contain real GLP-1 medication and should not be considered safe or effective treatments
Withdrawal Notice: Dietary Fatty Acids-effects on Cardiovascular Disease
Tirzepatide The Key Difference Between Semaglutide And Tirzepatide Lies In Their Mechanism Of Action